Pharmacyclics (PCYC) reports Q1 loss of $0.25
More News related to PCYC
- Pharmacyclics to Present at the ROTH Capital 22nd Annual OC Growth Conference
- Roth Capital Initiates Coverage on Pharmacyclics (PCYC) with a Buy
- Pharmacyclics to Present at the RBC Capital Markets Healthcare Investor Conference
- BWS Financial Downgrades Pharmacyclics (PCYC) to Hold; Moving to Sidelines
- Pharmacyclics (PCYC) Tops Q2 EPS by 9c
More News related to Earnings
- Highlights From PALM's Q3 Conference Call: Recent Underperformance is Extremely Disappointing; Guides Well Below for Q4 Revenues
- Perry Ellis (PERY) Sees Strong Rebound In Q4 Profits
- Perry Ellis International Inc. (PERY) Posts Q4 EPS of $0.64, Tops by 5c; Guides FY11 EPS
Pharmacyclics Inc. (Nasdaq: PCYC) reports Q1 loss of $0.25, below the analyst estimate of $0.19.
Related Categories
EarningsStocks Mentioned
+0.01Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
